Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.
暂无分享，去创建一个
L. Bastarache | K. Boyd | T. Hartert | R. Peebles | K. Niswender | Melissa H. Bloodworth | Mark Rusznak | D. Newcomb | J. Chappell | M. Moore | M. Stier | S. Toki | Weisong Zhou | Kasia Goleniewska | Jian Zhang | Connor C Pfister | Sandra Alvarez Calvillo | M. Rusznak | Tina V. Hartert | Martin L. Moore | Kevin D. Niswender | K. Goleniewska | Kelli L. Boyd | R. Peebles | James D. Chappell | Connor C. Pfister